(19)
(11) EP 4 479 063 A1

(12)

(43) Date of publication:
25.12.2024 Bulletin 2024/52

(21) Application number: 23710433.6

(22) Date of filing: 13.02.2023
(51) International Patent Classification (IPC): 
A61K 31/7004(2006.01)
A61P 31/14(2006.01)
 A61K 33/10(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 31/7004; A61K 33/10; A61P 31/14
 
C-Sets:
  1. A61K 31/7004, A61K 2300/00;
  2. A61K 33/10, A61K 2300/00;
(86) International application number:
PCT/IB2023/051295
(87) International publication number:
WO 2023/152719 (17.08.2023 Gazette 2023/33)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 14.02.2022 IT 202200002690

(71) Applicant: BIOCHEMICAL RESEARCH A.E.I.E.
33180 Norena-Asturias (ES)

(72) Inventor:
  • The inventor has waived his right to be thus mentioned.

(74) Representative: Mincone, Antimo 
Viale Europa 101
50126 Firenze
50126 Firenze (IT)

   


(54) COMPOSITION FOR USE IN THE PREVENTION AND THE TREATMENT OF INFECTIONS WITH SARS-COV-2 VIRUSES